Literature DB >> 31789319

A Reversible Silicon Oil-Induced Ocular Hypertension Model in Mice.

Jie Zhang1, Fang Fang2, Liang Li3, Haoliang Huang3, Hannah C Webber3, Yang Sun4, Vinit B Mahajan4, Yang Hu5.   

Abstract

Elevated intraocular pressure (IOP) is a well-documented risk factor for glaucoma. Here we describe a novel, effective method for consistently inducing stable IOP elevation in mice that mimics the post-operative complication of using silicone oil (SO) as a tamponade agent in human vitreoretinal surgery. In this protocol, SO is injected into the anterior chamber of the mouse eye to block the pupil and prevent inflow of aqueous humor. The posterior chamber accumulates aqueous humor and this in turn increases the IOP of the posterior segment. A single SO injection produces reliable, sufficient, and stable IOP elevation, which induces significant glaucomatous neurodegeneration. This model is a true replicate of secondary glaucoma in the eye clinic. To further mimic the clinical setting, SO can be removed from the anterior chamber to reopen the drainage pathway and allow inflow of aqueous humor, which is drained through the trabecular meshwork (TM) at the angle of the anterior chamber. Because IOP quickly returns to normal, the model can be used to test the effect of lowering IOP on glaucomatous retinal ganglion cells. This method is straightforward, does not require special equipment or repeat procedures, closely simulates clinical situations, and may be applicable to diverse animal species. However, minor modifications may be required.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31789319      PMCID: PMC6938455          DOI: 10.3791/60409

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  15 in total

1.  A novel method for the induction of experimental glaucoma using magnetic microspheres.

Authors:  Paulina A Samsel; Lilian Kisiswa; Jonathan T Erichsen; Stephen D Cross; James E Morgan
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-25       Impact factor: 4.799

2.  Differential susceptibility to experimental glaucoma among 3 mouse strains using bead and viscoelastic injection.

Authors:  Frances E Cone; Scott E Gelman; Janice L Son; Mary E Pease; Harry A Quigley
Journal:  Exp Eye Res       Date:  2010-06-26       Impact factor: 3.467

Review 3.  Glaucoma 2.0: neuroprotection, neuroregeneration, neuroenhancement.

Authors:  Elma E Chang; Jeffrey L Goldberg
Journal:  Ophthalmology       Date:  2012-02-18       Impact factor: 12.079

Review 4.  The Rodent Model of Glaucoma and Its Implications.

Authors:  Shida Chen; Xiulan Zhang
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2015 Jul-Aug

5.  The RNA binding protein RBPMS is a selective marker of ganglion cells in the mammalian retina.

Authors:  Allen R Rodriguez; Luis Pérez de Sevilla Müller; Nicholas C Brecha
Journal:  J Comp Neurol       Date:  2014-04-15       Impact factor: 3.215

6.  Optic neuropathy due to microbead-induced elevated intraocular pressure in the mouse.

Authors:  Huihui Chen; Xin Wei; Kin-Sang Cho; Guochun Chen; Rebecca Sappington; David J Calkins; Dong F Chen
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-01-05       Impact factor: 4.799

7.  Rat models for glaucoma research.

Authors:  John C Morrison; Elaine Johnson; William O Cepurna
Journal:  Prog Brain Res       Date:  2008       Impact factor: 2.453

Review 8.  Glaucoma management after vitreoretinal surgeries.

Authors:  Helen L Kornmann; Steven J Gedde
Journal:  Curr Opin Ophthalmol       Date:  2016-03       Impact factor: 3.761

Review 9.  Mouse models of retinal ganglion cell death and glaucoma.

Authors:  Stuart J McKinnon; Cassandra L Schlamp; Robert W Nickells
Journal:  Exp Eye Res       Date:  2008-12-07       Impact factor: 3.467

Review 10.  Silicone oil induced glaucoma: a review.

Authors:  Parul Ichhpujani; Anjana Jindal; L Jay Katz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-08-14       Impact factor: 3.117

View more
  6 in total

1.  Traumatic-noise-induced hair cell death and hearing loss is mediated by activation of CaMKKβ.

Authors:  Fan Wu; Kayla Hill; Qiaojun Fang; Zuhong He; Hongwei Zheng; Xianren Wang; Hao Xiong; Su-Hua Sha
Journal:  Cell Mol Life Sci       Date:  2022-04-19       Impact factor: 9.261

2.  Single-cell transcriptome analysis of regenerating RGCs reveals potent glaucoma neural repair genes.

Authors:  Liang Li; Fang Fang; Xue Feng; Pei Zhuang; Haoliang Huang; Pingting Liu; Liang Liu; Adam Z Xu; Lei S Qi; Le Cong; Yang Hu
Journal:  Neuron       Date:  2022-08-10       Impact factor: 18.688

3.  NMNAT2 is downregulated in glaucomatous RGCs, and RGC-specific gene therapy rescues neurodegeneration and visual function.

Authors:  Fang Fang; Pei Zhuang; Xue Feng; Pingting Liu; Dong Liu; Haoliang Huang; Liang Li; Wei Chen; Liang Liu; Yang Sun; Haowen Jiang; Jiangbin Ye; Yang Hu
Journal:  Mol Ther       Date:  2022-01-31       Impact factor: 12.910

4.  Longitudinal Morphological and Functional Assessment of RGC Neurodegeneration After Optic Nerve Crush in Mouse.

Authors:  Liang Li; Haoliang Huang; Fang Fang; Liang Liu; Yang Sun; Yang Hu
Journal:  Front Cell Neurosci       Date:  2020-04-29       Impact factor: 5.505

Review 5.  Role of Oxidative Stress in Ocular Diseases Associated with Retinal Ganglion Cells Degeneration.

Authors:  Eugene Yu-Chuan Kang; Pei-Kang Liu; Yao-Tseng Wen; Peter M J Quinn; Sarah R Levi; Nan-Kai Wang; Rong-Kung Tsai
Journal:  Antioxidants (Basel)       Date:  2021-12-05

6.  Comparing silicone oil-induced ocular hypertension with other inducible glaucoma models in mice.

Authors:  Jie Zhang; Yang Hu
Journal:  Neural Regen Res       Date:  2020-09       Impact factor: 5.135

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.